Chronic Limb-Threatening Ischemia: Clinical Trials

9 trials for Chronic Limb-Threatening Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Unknown 9
Phase 27Unknown 7

Follow Chronic Limb-Threatening Ischemia: new trials by email Literature Review of Chronic Limb-Threatening Ischemia trials Research Report on Chronic Limb-Threatening Ischemia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
Apixaban, ASA, Clopidogrel 75mg - Critical Limb Ischemia
Phase 3UnknownScience Valley Research Institute2002020-01-092021-04-20
Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
Allogeneic Mesenchymal Stromal Cell, Placebo - Peripheral Arterial Disease, Cardiovascular Diseases
Phase 2 / Phase 3UnknownMartin Teraa, MD, PhD602018-12-012018-05-03
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
CardioCell, Placebos - Critical Limb Ischemia
Phase 2 / Phase 3UnknownJohn Paul II Hospital, Krakow502018-04-192021-04-09
Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System
Autologous Bone Marrow Concentrate (aBMC), Placebo Control (diluted autologous peripheral blood) - Critical Limb Ischemia (CLI)
Phase 3UnknownCesca Therapeutics, Inc.2242017-01-012016-07-28
An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)
Ranger SL DEB - Lower Limb Ischemia, Peripheral Vascular Diseases
Phase 2 / Phase 3UnknownAssistance Publique - Hôpitaux de Paris302016-11-012018-05-18
VADOplex Critical Limb Ischemia Study
VADOplex system - Peripheral Artery Disease, Quality of Life
Phase 2 / Phase 3UnknownAsklepios Kliniken Hamburg GmbH382013-10-012014-01-13
Distal Venous Arterialisation of Ischemic Limb
distal venous arterialisation, Aspirin - Critical Limb Ischemia
Phase 2 / Phase 3UnknownClinical Centre of Serbia302009-09-012010-09-30
Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia
bone marrow derived mononuclear cells, placebo - Intermittent Claudication, Peripheral Vascular Diseases
Phase 2 / Phase 3UnknownLeiden University Medical Center1082007-10-012011-07-06
PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia
PTA with placement of paclitaxel-eluting stent, PTA - Peripheral Vascular Disease
Phase 2 / Phase 3UnknownNetherlands Society for Interventional Radiology1442007-08-012020-09-16

Narrower conditions

Peripheral Arterial Disease (3)  ·  Peripheral Vascular Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Intermittent Claudication (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)  ·  Vascular Diseases (1)

Broader conditions

Arterial Occlusive Diseases (9)  ·  Arteriosclerosis (9)  ·  Atherosclerosis (9)  ·  Chronic Disease (9)  ·  Disease Attributes (9)  ·  Ischemia (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Cardiovascular Diseases (8)  ·  Vascular Diseases (8)  ·  Peripheral Arterial Disease (6)  ·  Peripheral Vascular Diseases (6)  ·  Signs and Symptoms (1)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  apixaban (1)

Sponsors

Asklepios Kliniken Hamburg GmbH (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cesca Therapeutics, Inc. (1)  ·  Clinical Centre of Serbia (1)  ·  John Paul II Hospital, Krakow (1)  ·  Leiden University Medical Center (1)  ·  Martin Teraa, MD, PhD (1)  ·  Netherlands Society for Interventional Radiology (1)  ·  Science Valley Research Institute (1)

Countries

Netherlands (3)  ·  Brazil (1)  ·  France (1)  ·  Germany (1)  ·  Poland (1)  ·  Serbia (1)

Top investigators

Dalip Sethi, PhD (1)  ·  Gert Jan de Borst, MD, PhD (1)  ·  Hans Van Overhagen, MD PhD (1)  ·  Holger Lawall, MD (1)  ·  Jan HN Lindeman, MD, PhD (1)  ·  Marianne C Verhaar, MD, PhD (1)  ·  Predrag Vl Djoric, MD (1)

Results publications

PMID 19700099, PMID 26861113, PMID 28411244, PMID 29242062, PMID 30004916, PMID 32730905, PMID 35802393